Secondary Cytoreduction Versus Chemotherapy Alone in the Treatment of Patients with Recurrent Ovarian Cancer: Is a Randomized Trial Worthwhile?
Paolo Sammartino, Daniele Biacchi, Marialuisa FramarinoТом:
15
Мова:
english
DOI:
10.1007/s11912-013-0302-z
Date:
June, 2013
Файл:
PDF, 59 KB
english, 2013
File converter
Більше результатів пошуку
More benefits 
